Presented by: Cintia Kimura, Postdoctoral Scholar, General Surgery, Stanford University.
Talk Title: ” Introducing Plant-Based Diets for Patients Recovering From Colorectal Surgery.”
Bio: Dr. Kimura completed her training in colorectal surgery in Sao Paulo, Brazil. She is a postdoc in the Department of Surgery and her research focuses on the effect of different diets on the gut microbiome of patients undergoing colorectal surgery. She studies coaching interventions to help patients prepare and recover from colorectal surgery.
Presented by: Kazunari Sasaki, MD, Clinical Associate Professor, Division of Abdominal Transplant, Surgery, Stanford University.
Talk Title: “Looking for a Magic Spice”
Bio: Kazunari Sasaki, MD, is a Clinical Associate Professor, Division of Abdominal Transplant. He received his medical degree from Shiga University of Medical Science, Japan in 2004. He moved to the US in 2015 and completed abdominal transplant fellowship at Cleveland Clinic, where he was subsequently appointed to the surgical faculty. He specializes in liver transplantation hepatobiliary surgeries.
Contact Ana Mezynski for Zoom in details.
Mir Imran has accepted the invitation to be the 24th annual Fogarty guest lecturer. The date of the event is Friday September 30, 2022 at 4pm. It will be a hybrid event.
Mir Imran, Chairman & CEO of InCube Labs, is a prolific healthcare innovator and entrepreneur, who has been developing and commercializing breakthrough medical innovations for over 40 years.
Mir began his career as a healthcare entrepreneur in the late 1970’s with his pioneering contributions to the first FDA-approved Implantable Defibrillator (ICD). Since then, Mir has founded more than 20 life sciences companies and two tech companies, 15 of which have seen liquidity events (IPO/Acquisition). His most recent exit, Rani Therapeutics Holdings Inc., went public on Nasdaq in July 2021.
Mir’s inventions have saved the lives of millions of patients, and many have become the standards of care. He has developed innovative therapies for a number of chronic diseases, including, anemia, chronic pain, stroke, diabetes, and several cardiovascular conditions. His recent company, Rani Therapeutics, is revolutionizing the management of chronic diseases, by replacing painful injectable therapies with oral biologics.
Mir holds more than 800 issued & pending US patents. In 2016, QMed named Mir as one of the “Top 50 Medical Inventors of All Time”. Mir is a fellow of the National Academy of Engineering, the National Academy of Inventors and the American Institute of Medical & Biological Engineers. In 2009, Mir was inducted into the Rutgers University Hall of Distinguished Alumni.
Mir is also the co-founder & managing director of InCube Ventures, LP, a medtech/biotech venture capital fund. In addition, Mir serves on the boards of several life science companies, on the advisory board of the Lemelson Foundation, and is a trustee of the UCSC Foundation. He is also an Adjunct Professor of Bioengineering at the University of Pittsburgh and actively supports the promotion and teaching of innovation and entrepreneurship at colleges and universities. As a philanthropist, Mir is passionately supporting education in India and US, especially for underprivileged students.